Isoniazid or rifampicin versus bacillus Calmette-Guérin (BCG). 1991

P A Camargos, and J I Martins, and M T Fonseca
Departmento de Pediatria da Faculdae de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, Brasil.

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

P A Camargos, and J I Martins, and M T Fonseca
June 1951, The Journal of experimental medicine,
P A Camargos, and J I Martins, and M T Fonseca
July 1950, Concours medical,
P A Camargos, and J I Martins, and M T Fonseca
April 1950, Medecine et hygiene,
P A Camargos, and J I Martins, and M T Fonseca
January 1951, Biologie medicale,
P A Camargos, and J I Martins, and M T Fonseca
January 1979, Pharmacology & therapeutics,
P A Camargos, and J I Martins, and M T Fonseca
August 2001, Diagnostic cytopathology,
P A Camargos, and J I Martins, and M T Fonseca
January 2002, Duodecim; laaketieteellinen aikakauskirja,
P A Camargos, and J I Martins, and M T Fonseca
January 2021, International braz j urol : official journal of the Brazilian Society of Urology,
P A Camargos, and J I Martins, and M T Fonseca
October 1978, Proceedings of the National Academy of Sciences of the United States of America,
P A Camargos, and J I Martins, and M T Fonseca
March 1975, Experientia,
Copied contents to your clipboard!